Lung Cancer Animated Infographic

Boehringer Ingelheim

Lung cancer is the most common cancer in the world, with 1.61 million new cases annually.¹

More than two-thirds of lung cancers are diagnosed at a late stage, when the cancer has spread to other parts of the body meaning curative treatment is not possible. Whilst there have been advances in diagnosis and treatment, unfortunately only 7% of lung cancer patients survive for at least five years after diagnosis.² Early diagnosis helps to ensure better outcomes.

Learn more about lung cancer by launching our interactive infographic above. Bookmark this page and check back for regular updates to the lung cancer story.

1. Ferlay J et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; EPub Ahead of print.
2. Cancer Research UK. CancerStats key facts on lung cancer and smoking. CancerStats – Key Facts 2009. [Online] Available at: http://info.cancerresearchuk.org/cancerstats/types/lung/ [Last Accessed October 2011].

Source for healthcare professionals: www.inoncology.com
* Nintedanib (BIBF 1120), afatinib (BIBW 2992) and volasertib (BI 6727) are investigational compounds. Their safety and efficacy have not yet been fully established.

† Not an official event of the 2012 ASCO Annual Meeting. Not sponsored or endorsed by ASCO or the Conquer Cancer Foundation.

Boehringer Ingelheim on